Main page content

Advisory: An Introduction to Extended-Release Injectable Naltrexone for the Treatment of People with Opioid Dependence

Cover of Publication

This advisory gives an overview of extended-release injectable naltrexone for people with opioid dependence. It discusses how it differs from other medication-assisted treatments, safety concerns, and patients most likely to benefit.

Publication ID
SMA12-4682
Publication Date

Units per Product

 

You May Also Be Interested In